iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Proquility Private Wealth Partners LLC

Proquility Private Wealth Partners LLC lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,426 shares of the financial services provider’s stock after selling 151 shares during the quarter. Proquility Private Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $2,965,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Hsbc Holdings PLC grew its position in shares of iShares Biotechnology ETF by 47.1% in the second quarter. Hsbc Holdings PLC now owns 3,670 shares of the financial services provider’s stock valued at $504,000 after purchasing an additional 1,175 shares during the period. AE Wealth Management LLC increased its holdings in iShares Biotechnology ETF by 10.7% in the 2nd quarter. AE Wealth Management LLC now owns 2,034 shares of the financial services provider’s stock valued at $279,000 after purchasing an additional 196 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 34.2% during the second quarter. EverSource Wealth Advisors LLC now owns 4,622 shares of the financial services provider’s stock worth $684,000 after purchasing an additional 1,177 shares in the last quarter. Bank of Montreal Can grew its stake in shares of iShares Biotechnology ETF by 2.6% in the second quarter. Bank of Montreal Can now owns 36,198 shares of the financial services provider’s stock valued at $5,086,000 after buying an additional 920 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. raised its holdings in shares of iShares Biotechnology ETF by 6.0% during the 2nd quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock valued at $242,000 after buying an additional 100 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $136.10 on Wednesday. The business has a 50 day moving average price of $136.15 and a two-hundred day moving average price of $141.84. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.